A-26/27-17 In re: Accutane Litigation (079933)
Was plaintiffs’ evidence regarding a failure to warn sufficient to overcome the presumption of adequacy afforded by the Products Liability Act for an FDA-approved warning; and what is the appropriate resolution of the choice-of-law issues?
Watch the
- Certification granted : Dec. 8, 2017
- Posted: Dec. 8, 2017
- Argued: April 23, 2018
- Decided: Oct. 3, 2018